Cathie Wood's ARK Invest Boosts AI, Amazon, AMD Holdings Amid Portfolio Shift

Cathie Wood's Ark Invest has been actively adjusting its portfolio with a clear focus on healthcare, AI, and platform software stocks while reducing exposure to other growth tech companies. Recently, Ark made significant purchases in health AI firm Tempus AI, increasing its holdings to $284.8 million, and also added shares in Amazon, Advanced Micro Devices (AMD), and Guardant Health. Conversely, Ark trimmed positions in CoreWeave and Palantir Technologies, both of which had experienced strong rallies. The firm also bought shares in 10X Genomics and eToro Group, signaling confidence in selective healthcare and fintech sectors. These moves reflect Ark's strategic shift toward leveraging AI and healthcare innovation across its ETFs, including ARKW, ARKK, and ARKG. Ark's buying activity in Amazon underscores confidence in the company's resilience amid macroeconomic challenges, despite mixed retail investor sentiment.